[Federal Register Volume 83, Number 213 (Friday, November 2, 2018)]
[Notices]
[Pages 55171-55172]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23976]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Centers for Disease Control and Prevention Board of Scientific 
Counselors, National Center for Injury Prevention and Control, (BSC, 
NCIPC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Injury Prevention and Control, (BSC, NCIPC). This 
meeting is open to the public limited only by the space and ports 
available. The meeting room accommodates 70 participants and there will 
be 75 ports available. Due to the limited availability of phone line 
ports, we are encouraging the pubic to please register using the link 
provided: Register Here. There will be a public comment period at the 
end of the day from 03:30 p.m.--04:00 p.m.

DATES: The meeting will be held on December 12, 2018, 09:00 a.m. to 
04:30 p.m., EST.

ADDRESSES: Center for Disease Control and Prevention, Chamblee Campus, 
Building 106, Conference Room 1-A, 4770 Buford Highway, Atlanta, 
Georgia 30341 and via Teleconference: Dial-In Number: 1-888-780-9652, 
Participant Code: 8435823.

FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., 
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 
Buford Highway, NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770) 
488-1430. Email address: [email protected]

SUPPLEMENTARY INFORMATION: 
    Purpose: The Board will: (1) Conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to

[[Page 55172]]

the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in preventing and suppressing communicable and 
non-communicable diseases and other preventable conditions and in 
promoting health and well-being; and (3) conduct and assist in research 
and control activities related to injury. The Board of Scientific 
Counselors makes recommendations regarding policies, strategies, 
objectives, and priorities; and reviews progress toward injury 
prevention goals and provides evidence in injury prevention-related 
research and programs. The Board also provides advice on the 
appropriate balance of intramural and extramural research, the 
structure, progress and performance of intramural programs. The Board 
is designed to provide guidance on extramural scientific program 
matters, including the: (1) Review of extramural research concepts for 
funding opportunity announcements; (2) conduct of Secondary Peer Review 
of extramural research grants, cooperative agreements, and contracts 
applications received in response to the funding opportunity 
announcements as it relates to the Center's programmatic balance and 
mission; (3) submission of secondary review recommendations to the 
Center Director of applications to be considered for funding support; 
(4) review of research portfolios, and (5) review of program proposals.
    Matters to be Considered: The Board of Scientific Counselors will 
discuss science matters to include research strategies needed to guide 
the Center's focus on reducing opioid overdose and to review the 
recommendations from the opioid prescribing for acute and chronic pain 
workgroup. Agenda items are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-23976 Filed 11-1-18; 8:45 am]
 BILLING CODE 4163-19-P